Stephanie Berg: The power of the cooperative groups!
Toni Choueiri shared a post by Stephanie Berg, Medical oncologist at Lank Center for Genitourinary Oncology, on X/Twitter, adding:
“FIVE years while still staying relevant. Grit, more grit, and some more — a journey like few others. Congrats to the Alliance for Clinical Trials in Oncology investigators, Tian Zhang, as well as Daniel George, Michael Morris, Matt Galsky, Jonathan Rosenberg and the statistical team.
Thank you to all the patients! Tian: we have done it! Now off to more grit!”
Quoting Stephanie Berg’s post:
Wow! Congrats to the A031704 team and all of the patients! 5 years in the making. The power of the cooperative groups!”
Source: Toni Choueiri/X and Stephanie Berg/X
Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.
He received the George Canellos Award for Excellence in Clinical Investigation and Patient Care from DFCI in 2013, the Eugene Schonfeld Award from the Kidney Cancer Association (KCA) in 2016, and is a 2021 Giants of Cancer Care inductee.
He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, KidneyCan Board, the National Cancer Institute (NCI) GU Steering Committee, and is past Chairman (2015-2018) of the Medical and Scientific Steering Committee of the KCA.
Dr. Choueiri is an elected member of the American Society of Clinical Investigation (ASCI). In addition, he is an Aresty Scholar from the Wharton School of Business at the University of Pennsylvania.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023